Nancy Monroy‐Jaramillo

889 total citations
43 papers, 577 citations indexed

About

Nancy Monroy‐Jaramillo is a scholar working on Molecular Biology, Biological Psychiatry and Psychiatry and Mental health. According to data from OpenAlex, Nancy Monroy‐Jaramillo has authored 43 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Biological Psychiatry and 10 papers in Psychiatry and Mental health. Recurrent topics in Nancy Monroy‐Jaramillo's work include Tryptophan and brain disorders (11 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Nancy Monroy‐Jaramillo is often cited by papers focused on Tryptophan and brain disorders (11 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Nancy Monroy‐Jaramillo collaborates with scholars based in Mexico, United States and Spain. Nancy Monroy‐Jaramillo's co-authors include Marisol López, Consuelo Walss‐Bass, Ingrid Fricke-Galindo, Adrián LLerena, Helgi Jung–Cook, Hélène Tronchère, Valérie Tosch, Jean‐Louis Mandel, Jocelyn Laporte and Edmar Zanoteli and has published in prestigious journals such as Human Molecular Genetics, Journal of Affective Disorders and Schizophrenia Bulletin.

In The Last Decade

Nancy Monroy‐Jaramillo

42 papers receiving 565 citations

Peers

Nancy Monroy‐Jaramillo
Nancy Monroy‐Jaramillo
Citations per year, relative to Nancy Monroy‐Jaramillo Nancy Monroy‐Jaramillo (= 1×) peers Gonzálo Arboleda

Countries citing papers authored by Nancy Monroy‐Jaramillo

Since Specialization
Citations

This map shows the geographic impact of Nancy Monroy‐Jaramillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Monroy‐Jaramillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Monroy‐Jaramillo more than expected).

Fields of papers citing papers by Nancy Monroy‐Jaramillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Monroy‐Jaramillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Monroy‐Jaramillo. The network helps show where Nancy Monroy‐Jaramillo may publish in the future.

Co-authorship network of co-authors of Nancy Monroy‐Jaramillo

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Monroy‐Jaramillo. A scholar is included among the top collaborators of Nancy Monroy‐Jaramillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Monroy‐Jaramillo. Nancy Monroy‐Jaramillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
López, Marisol, et al.. (2023). Longitudinal Changes in Mitochondrial DNA Copy Number and Telomere Length in Patients with Parkinson’s Disease. Genes. 14(10). 1913–1913. 8 indexed citations
2.
Rodríguez‐Agudelo, Yaneth, et al.. (2023). Relationship between APOE, PER2, PER3 and OX2R Genetic Variants and Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease. International Journal of Environmental Research and Public Health. 20(5). 4412–4412. 7 indexed citations
3.
Alcaraz-Zubeldia, Mireya, et al.. (2022). Influence of glutathione-related genetic variants on the oxidative stress profile of Mexican patients with psychotic disorders. Brazilian Journal of Psychiatry. 45(2). 117–126. 1 indexed citations
4.
Fricke-Galindo, Ingrid, et al.. (2022). Impact of COMT, PRODH and DISC1 Genetic Variants on Cognitive Performance of Patients with Schizophrenia. Archives of Medical Research. 53(4). 388–398. 6 indexed citations
5.
Fricke-Galindo, Ingrid, Helgi Jung–Cook, Iris E. Martínez‐Juárez, et al.. (2021). Relevance of NR1I2 Variants on Carbamazepine Therapy in Mexican Mestizos with Epilepsy at a Tertiary-Care Hospital. Pharmacogenomics. 22(15). 983–996.
6.
Cabrera‐Mendoza, Brenda, José Jaime Martínez‐Magaña, Nancy Monroy‐Jaramillo, et al.. (2021). Candidate pharmacological treatments for substance use disorder and suicide identified by gene co‐expression network‐based drug repositioning. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 186(3). 193–206. 4 indexed citations
7.
Monroy‐Jaramillo, Nancy, et al.. (2021). Working Memory Impairment as an Endophenotypic Marker in Patients with Schizophrenia: Failures in Encoding or Maintenance?. Neuropsychobiology. 80(4). 352–358. 2 indexed citations
8.
Fries, Gabriel R., Gabriela Delevati Colpo, Nancy Monroy‐Jaramillo, et al.. (2020). The anti-aging effects of lithium in lymphoblastoid cell lines from patients with bipolar disorder and controls. Journal of Psychiatric Research. 128. 38–42. 12 indexed citations
9.
Monroy‐Jaramillo, Nancy, et al.. (2018). Phenotypic Variability in a Mexican Mestizo Family with Retinal Vasculopathy with Cerebral Leukodystrophy and TREX1 Mutation p.V235Gfs*6. Revista de investigaci�n Cl�nica. 70(2). 68–75. 5 indexed citations
10.
Cabrera‐Mendoza, Brenda, Nancy Monroy‐Jaramillo, Gabriel R. Fries, et al.. (2018). Brain Gene Expression Pattern of Subjects with Completed Suicide and Comorbid Substance Use Disorder. PubMed. 5(1). 60–73. 18 indexed citations
11.
Monroy‐Jaramillo, Nancy, et al.. (2017). Leukocyte telomere length in Hispanic schizophrenia patients under treatment with olanzapine. Journal of Psychiatric Research. 90. 26–30. 12 indexed citations
12.
Sesar, Ángel, Pilar Cacheiro, Marisol López, et al.. (2016). Synaptotagmin XI in Parkinson's disease: New evidence from an association study in Spain and Mexico. Journal of the Neurological Sciences. 362. 321–325. 18 indexed citations
13.
Monroy‐Jaramillo, Nancy, et al.. (2014). Pharmacogenetic potential biomarkers for carbamazepine adverse drug reactions and clinical response. Drug metabolism and drug interactions. 29(2). 67–79. 19 indexed citations
14.
Monroy‐Jaramillo, Nancy, et al.. (2014). Genetic mutations in early‐onset Parkinson's disease Mexican patients: Molecular testing implications. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 165(3). 235–244. 13 indexed citations
15.
Monroy‐Jaramillo, Nancy, et al.. (2012). High frequency of Parkin exon rearrangements in Mexican‐mestizo patients with early‐onset Parkinson's disease. Movement Disorders. 27(8). 1047–1051. 16 indexed citations
16.
López, Marisol, Pedro Dorado, Nancy Monroy‐Jaramillo, et al.. (2011). Pharmacogenetics of the antiepileptic drugs phenytoin and lamotrigine. Drug metabolism and drug interactions. 26(1). 5–12. 24 indexed citations
17.
Yescas, Petra, Marisol López, Nancy Monroy‐Jaramillo, et al.. (2010). Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease. Neuroscience Letters. 485(2). 79–82. 22 indexed citations
18.
Monroy‐Jaramillo, Nancy, Luis Macías‐Kauffer, & Osvaldo M. Mutchinick. (2008). Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) in two Mexican brothers harboring a novel mutation in the ECGF1 gene. European Journal of Medical Genetics. 51(3). 245–250. 14 indexed citations
19.
Monroy‐Jaramillo, Nancy, et al.. (2002). New mutations in the CBFA1 gene in two Mexican patients with cleidocranial dysplasia. Clinical Genetics. 61(5). 349–353. 14 indexed citations
20.
Monroy‐Jaramillo, Nancy, Marisol López, Alicia Cervantes, et al.. (2001). Microsatellite analysis in Turner syndrome: Parental origin of X chromosomes and possible mechanism of formation of abnormal chromosomes. American Journal of Medical Genetics. 107(3). 181–189. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026